PD-1 blockade with pembrolizumab for classical Hodgkin lymphoma after autologous stem cell transplantationPhilippe Armand, Alex F. Herrera, Eric D. Jacobsen et al.|Blood|2019Cited by 187
PD-1 blockade for diffuse large B-cell lymphoma after autologous stem cell transplantationMatthew J. Frigault, Robin Joyce, Philippe Armand et al.|Blood Advances|2020Cited by 65
Minimal residual disease in patients with diffuse large B-cell lymphoma undergoing autologous stem cell transplantationReid W. Merryman, Philippe Armand, Robert Redd et al.|Blood Advances|2022Cited by 19
Immune Reconstitution following High-Dose Chemotherapy and Autologous Stem Cell Transplantation with or without Pembrolizumab Maintenance Therapy in Patients with LymphomaReid W. Merryman, Jerome Ritz, Robert Redd et al.|Transplantation and Cellular Therapy|2021Cited by 17
Interim Positron Emission Tomography During Frontline Chemoimmunotherapy for Follicular LymphomaReid W. Merryman, Heather A. Jacene, Laure Michaud et al.|HemaSphere|2023Cited by 11